Ann C. Mladek

Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma

Rachael A. Vaubel, Shulan Tian, Dioval Remonde et al. · Clinical Cancer Research · 2019 · 223 citations · Full text

Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy.

Jeffrey S. Eshleman, Brett L. Carlson, Ann C. Mladek et al. · PubMed · 2002 · 200 citations

Tumor Biology, Mammalian Target, Radiation Medicine +13

Molecular Cloning and Characterization of TIEG2Reveals a New Subfamily of Transforming Growth Factor-β-inducible Sp1-like Zinc Finger-encoding Genes Involved in the Regulation of Cell Growth

Tiffany Cook, Brian Gebelein, Kristin Mesa et al. · Journal of Biological Chemistry · 1998 · 188 citations · Full text

Transcriptional Regulation, Developmental Biology, Tissue Development +14

Inhibition of Histone Deacetylation Potentiates the Evolution of Acquired Temozolomide Resistance Linked to MGMT Upregulation in Glioblastoma Xenografts

Gaspar J. Kitange, Ann C. Mladek, Brett L. Carlson et al. · Clinical Cancer Research · 2012 · 148 citations

Delineation of<i>MGMT</i>Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma

Shiv K. Gupta, Sani H. Kizilbash, Brett L. Carlson et al. · JNCI Journal of the National Cancer Institute · 2015 · 120 citations · Full text